» Articles » PMID: 29121124

Atopic Dermatitis Prevention and Treatment

Overview
Journal Cutis
Specialty Dermatology
Date 2017 Nov 10
PMID 29121124
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Atopic dermatitis (AD) is the cause of substantial morbidity including severe pruritus and impaired personal and familial quality of life. Furthermore, the rising incidence and familial association of AD have highlighted the need for disease prevention. It is largely genetic in nature and cannot be avoided in all cases. However, low-risk prevention strategies have been attempted to reduce triggering of first onset of AD in predisposed individuals. Therapeutics for active disease include trigger avoidance, barrier repair, topical medicaments including topical corticosteroids (TCs) and nonsteroidal agents, phototherapy, and antibacterial interventions.

Citing Articles

Exploring the Therapeutic Potential of Extracellular Vesicles Anchored to the Sea Cucumber Extracellular Matrix for Treating Atopic Dermatitis.

Jo S, Kim S, Heo S, Cho H, Esfahani I, Park S Biomater Res. 2025; 29:0154.

PMID: 39990978 PMC: 11842673. DOI: 10.34133/bmr.0154.


The Effects of Mucopolysaccharide Polysulfate on Steroid-Induced Tight Junction Barrier Dysfunction in Human Epidermal Keratinocytes and a 3D Skin Model.

Koda A, Ishii Y, Kashiwagi A, Fujikawa M, Kikuchi K, Hashimoto R Skin Pharmacol Physiol. 2023; 36(4):186-194.

PMID: 36966539 PMC: 10652656. DOI: 10.1159/000529962.


Anti-pruritic effect of isothiocyanates: Potential involvement of toll-like receptor 3 signaling.

Moriyama M, Konno M, Serizawa K, Yuzawa N, Majima Y, Hayashi I Pharmacol Res Perspect. 2022; 10(6):e01038.

PMID: 36507603 PMC: 9741980. DOI: 10.1002/prp2.1038.


Acne Vulgaris, Atopic Dermatitis and Rosacea: The Role of the Skin Microbiota-A Review.

Condro G, Guerini M, Castello M, Perugini P Biomedicines. 2022; 10(10).

PMID: 36289784 PMC: 9599554. DOI: 10.3390/biomedicines10102523.


Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.

Sedeh F, Henning M, Jemec G, Ibler K Acta Derm Venereol. 2022; 102:adv00764.

PMID: 35818735 PMC: 9574696. DOI: 10.2340/actadv.v102.2075.